Early intervention with Kan Jang® to treat upper-respiratory tract infections: A randomized, quadruple-blind study-Reference-Cited by-同舟云学术

Early intervention with Kan Jang® to treat upper-respiratory tract infections: A randomized, quadruple-blind study

Published:2021-11 Issue:6 Volume:11 Page:552-562
ISSN:2225-4110
Container-title:Journal of Traditional and Complementary Medicine
language:en
Short-container-title:Journal of Traditional and Complementary Medicine

Author:

Narimanyan Mikayel,Jamalyan Kristina,Balyan Anna,Barth Anders,Palm Staffan,Wikman Georg,Panossian Alexander^ORCID

Publisher

Elsevier BV

Subject

Complementary and alternative medicine

Reference32 articles.

1. Exposure to cold and acute upper respiratory tract infection;Eccles;Rhinology,2015

2. Upper respiratory infections;Grief;Prim Care,2013

3. Viral and bacterial interactions in the upper respiratory tract;Bosch;PLoS Pathog,2013

4. Principles of appropriate antibiotic use for treatment of nonspecific upper respiratory tract infections in adults: background;Gonzales;Ann Emerg Med,2001

5. Botanical drugs and supplements affecting the immune response in the time of COVID-19: implications for research and clinical practice;Brendler;Phytother Res,2020

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Development and Optimization of Andrographis paniculata Extract-Loaded Self-Microemulsifying Drug Delivery System Using Experimental Design Model;Pharmaceutics;2024-01-24

2. Andrographolide, diterpenoid constituent of Andrographis paniculata: Review on botany, phytochemistry, molecular docking analysis, and pharmacology;Annales Pharmaceutiques Françaises;2024-01

3. The phytochemical study of Eleutherococcus senticosus (Rupr. & Maxim) leaves in hydroponics and soil culture;Functional Foods in Health and Disease;2023-11-02

4. Andrographis: Immune Modulating and Anti-Inflammatory Effects;Integrative and Complementary Therapies;2023-10-01

5. Efficacy of Kan Jang® in Patients with Mild COVID-19: A Randomized, Quadruple-Blind, Placebo-Controlled Trial;Pharmaceuticals;2023-08-22